News Category Global Banking & Finance Reviews
Founding Dean of UC San Diego Rady School of Business Joins Releviate Therapeutics’ Board of Directors
Founding Dean of UC San Diego Rady School of Business Joins Releviate Therapeutics’ Board of Directors Releviate Therapeutics, a bio-pharmaceutical company addressing the needs of patients suffering from chronic pain, today welcomes Robert Sullivan, founding dean emeritus of UC San Diegos Rady School of Management, as a director on its board. Sullivan brings Releviate over 30 years of experience in entrepreneurship, technology innovation and operations management. As a part of the board, he will manage investor relations and strategize with other directors on opportunities to drive the companys growth.
TuanChe Announces Unaudited Third Quarter 2020 Financial Results
News provided by
Share this article
Share this article
BEIJING, Dec. 18, 2020 /PRNewswire/ TuanChe Limited ( TuanChe, Company, we or our ) (NASDAQ: TC), a leading omni-channel automotive marketplace in China, today announced its unaudited financial results for the third quarter ended September 30, 2020.
Key Third Quarter 2020 Financial and Operating Metrics Compared with the Prior Year Period
The Company s financial and operational results for the third quarter of 2020 continued to be adversely impacted by the COVID-19 pandemic:
Net revenues decreased by 26.2% to RMB100.0 million (US$14.7 million) from RMB135.6 million.
Gross profit decreased by 22.6% to RMB72.1 million (US$10.6 million) from RMB93.2 million. Gross margin increased to 72.1% from 68.7%.